APPLICATION
NDA211367
TYPE
NDA
ORIGINAL APPROVAL
2019-05-23
LATEST ACTION
2019-05-23
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
SLYND · ReferencePrescription
DROSPIRENONE 4MG · TABLET · ORAL
Approval history
2019-05-23Type 2 - New Active Ingredient and Type 3 - New Dosage Form · Original · standard — Label ↗AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.